Regarding the aforementioned inconsistent interplay of RBP-4 with diabetes and obesity, it becomes more valuable to assess RBP4 levels among diabetic and non-diabetic cohorts. The gene discussed is RBP4; the disease is obesity due to melanocortin 4 receptor deficiency.